Location: United Kingdom
Total raised: $94.43M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.10.2025 | Series A | $94.43M | Eli Lilly ... |
Mentions in press and media 4
| Date | Title | Description |
| 07.10.2025 | Precision Oncology Pioneer Trogenix Secures Landmark €80M Series A for Curative Cancer Fight | Trogenix, an Edinburgh-based biotech, secured a monumental €80 million Series A funding. This capital empowers its pursuit of curative cancer treatments for aggressive solid tumors. The firm's Odysseus platform uses advanced gene control an... |
| 06.10.2025 | Calculus invests in Trogenix | - |
| 06.10.2025 | Edinburgh-based BioTech Trogenix lands €80 million to accelerate curative cancer treatments | Trogenix Ltd, a Scottish BioTech company dedicated to innovative cancer therapies, announced the completion of its Series A financing, raising €80 million, to advance its pipeline of potentially curative cancer therapies across multiple agg... |
| 06.10.2025 | Edin Uni Spinout Trogenix Raises £70M to Treat Aggressive Cancers | University of Edinburgh spinout Trogenix, which is developing curative therapies for aggressive, treatment-resistant cancers, has completed Series A financing of £70 million. The funding will allow the biotech company to rapidly advance its... |